{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:42:02Z","timestamp":1786470122448,"version":"build-2736575974"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"DOI":"10.1007\/s15010-026-02924-6","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:58:35Z","timestamp":1786460315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ebola virus disease in the modern era: pathogenesis, therapeutic advances, vaccine strategies, and global health preparedness"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3585-6664","authenticated-orcid":false,"given":"Dola","family":"Sundeep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3638-4822","authenticated-orcid":false,"given":"Kovuri","family":"Umadevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-9133","authenticated-orcid":false,"given":"Jaweria","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6606-374X","authenticated-orcid":false,"given":"Nayanika","family":"Tummala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"1","key":"2924_CR1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/21505594.2021.1898169","volume":"12","author":"S Yamaoka","year":"2021","unstructured":"Yamaoka S, Ebihara H. Pathogenicity and virulence of ebolaviruses with species- and variant-specificity. Virulence. 2021;12(1):885\u2013901. https:\/\/doi.org\/10.1080\/21505594.2021.1898169.","journal-title":"Virulence"},{"key":"2924_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s40121-015-0079-5","volume":"4","author":"MJ Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez MJ, Salim AM, Hurtado JC, et al. Ebola virus infection: overview and update on prevention and treatment. Infect Dis Ther. 2015;4:365\u201390. https:\/\/doi.org\/10.1007\/s40121-015-0079-5.","journal-title":"Infect Dis Ther"},{"issue":"10174","key":"2924_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","volume":"393","author":"D Malvy","year":"2019","unstructured":"Malvy D, McElroy AK, de Clerck H, G\u00fcnther S, van Griensven J. Ebola virus disease. Lancet. 2019;393(10174):936\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(18)33132-5.","journal-title":"Lancet"},{"key":"2924_CR4","doi-asserted-by":"publisher","unstructured":"Hussein HA. Brief review on ebola virus disease and one health approach. Heliyon. 2023;9(8). https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19036.","DOI":"10.1016\/j.heliyon.2023.e19036"},{"issue":"8","key":"2924_CR5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cmi.2025.04.007","volume":"31","author":"G Pellejero-Sagastiz\u00e1bal","year":"2025","unstructured":"Pellejero-Sagastiz\u00e1bal G, Bulescu C, Gupta N, Jokelainen P, Gkrania-Klotsas E, Barac A, Goorhuis A, Jacob ST, Agnandji ST, Ntoumi F, Mora-Rillo M. Delayed correct diagnoses in emerging disease outbreaks: historical patterns and lessons for contemporary responses. Clin Microbiol Infect. 2025;31(8):1298\u2013306. https:\/\/doi.org\/10.1016\/j.cmi.2025.04.007.","journal-title":"Clin Microbiol Infect"},{"key":"2924_CR6","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/ijerph21091238","volume":"21","author":"T Kamalrathne","year":"2024","unstructured":"Kamalrathne T, Amaratunga D, Haigh R, Kodituwakku L, Rupasinghe C. Epidemic and pandemic preparedness and response in a multi-hazard context: COVID-19 pandemic as a point of reference. Int J Environ Res Public Health. 2024;21:1238. https:\/\/doi.org\/10.3390\/ijerph21091238.","journal-title":"Int J Environ Res Public Health"},{"key":"2924_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12967-014-0362-3","volume":"13","author":"F Chiappelli","year":"2015","unstructured":"Chiappelli F, Bakhordarian A, Thames AD, et al. Ebola: translational science considerations. J Transl Med. 2015;13:11. https:\/\/doi.org\/10.1186\/s12967-014-0362-3.","journal-title":"J Transl Med"},{"key":"2924_CR8","doi-asserted-by":"publisher","unstructured":"Rivera A, Messaoudi I. Molecular mechanisms of Ebola pathogenesis. J Leukoc Biol. Nov 2016;100(5):889\u2013904. https:\/\/doi.org\/10.1189\/jlb.4RI0316-099RR.","DOI":"10.1189\/jlb.4RI0316-099RR"},{"key":"2924_CR9","doi-asserted-by":"publisher","first-page":"102375","DOI":"10.1016\/j.jaut.2019.102375","volume":"106","author":"M Rojas","year":"2020","unstructured":"Rojas M, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ram\u00edrez-Santana C, Ansari AA, Gershwin ME, Anaya JM. Ebola virus disease: An emerging and re-emerging viral threat. J Autoimmun. 2020;106:102375. https:\/\/doi.org\/10.1016\/j.jaut.2019.102375.","journal-title":"J Autoimmun"},{"issue":"3","key":"2924_CR10","doi-asserted-by":"publisher","first-page":"e1012038","DOI":"10.1371\/journal.ppat.1012038","volume":"20","author":"LE El Ayoubi","year":"2024","unstructured":"El Ayoubi LE, Mahmoud O, Zakhour J, Kanj SS. Recent advances in the treatment of Ebola disease: a brief overview. PLoS Pathog. 2024;20(3):e1012038. https:\/\/doi.org\/10.1371\/journal.ppat.1012038.","journal-title":"PLoS Pathog"},{"key":"2924_CR11","doi-asserted-by":"publisher","first-page":"721328","DOI":"10.3389\/fimmu.2021.721328","volume":"12","author":"O Tshiani Mbaya","year":"2021","unstructured":"Tshiani Mbaya O, Mukumbayi P, Mulangu S. Review: insights on current FDA-approved monoclonal antibodies against ebola virus infection. Front Immunol. 2021;12:721328. https:\/\/doi.org\/10.3389\/fimmu.2021.721328.","journal-title":"Front Immunol"},{"key":"2924_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12985-025-02766-y","volume":"22","author":"EM Kikwango","year":"2025","unstructured":"Kikwango EM, Akilimali PZ, Tran NT. Impact of most promising Ebola therapies on survival: a secondary analysis during the tenth outbreak in the Democratic Republic of Congo. Virol J. 2025;22:144. https:\/\/doi.org\/10.1186\/s12985-025-02766-y.","journal-title":"Virol J"},{"key":"2924_CR13","doi-asserted-by":"publisher","unstructured":"Mukadi-Bamuleka D, Edidi-Atani F, Morales-Betoulle ME, Legand A, Nkuba-Ndaye A, Bulabula-Penge J, Mbala-Kingebeni P, Crozier I, Mambu-Mbika F, Whitmer S, Mbaya OT. Fatal meningoencephalitis associated with Ebola virus persistence in two survivors of Ebola virus disease in the Democratic Republic of the Congo: a case report study. Lancet Microbe. 2024;5(10). https:\/\/doi.org\/10.1016\/S2666-5247(24)00137-X.","DOI":"10.1016\/S2666-5247(24)00137-X"},{"issue":"7","key":"2924_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1469-0691.2011.03535.x","volume":"17","author":"EM Leroy","year":"2011","unstructured":"Leroy EM, Gonzalez JP, Baize S. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect. 2011;17(7):964\u201376. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03535.x.","journal-title":"Clin Microbiol Infect"},{"key":"2924_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/82_2017_11","volume-title":"Marburg- and Ebolaviruses. Current Topics in Microbiology and Immunology","author":"C Mu\u00f1oz-Fontela","year":"2017","unstructured":"Mu\u00f1oz-Fontela C, McElroy AK. Ebola virus disease in humans: pathophysiology and immunity. In: M\u00fchlberger E, Hensley L, Towner J, editors. Marburg- and Ebolaviruses. Current topics in microbiology and immunology. Volume 411. Cham: Springer; 2017. https:\/\/doi.org\/10.1007\/82_2017_11."},{"key":"2924_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40779-015-0035-4","volume":"2","author":"WB Liu","year":"2015","unstructured":"Liu WB, Li ZX, Du Y, et al. Ebola virus disease: from epidemiology to prophylaxis. Military Med Res. 2015;2:7. https:\/\/doi.org\/10.1186\/s40779-015-0035-4.","journal-title":"Military Med Res"},{"key":"2924_CR17","doi-asserted-by":"publisher","unstructured":"Hasan S, Ahmad SA, Masood R, Saeed S. Ebola virus: A global public health menace. J Family Med Prim Care 8(7):p 2189\u2013201, July 2019. | https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_297_19","DOI":"10.4103\/jfmpc.jfmpc_297_19"},{"issue":"3","key":"2924_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jiph.2020.12.030","volume":"14","author":"S Gupta","year":"2021","unstructured":"Gupta S, Gupta N, Yadav P, Patil D. Ebola virus outbreak preparedness plan for developing nations: lessons learnt from affected countries. J Infect Public Health. 2021;14(3):293\u2013305. https:\/\/doi.org\/10.1016\/j.jiph.2020.12.030.","journal-title":"J Infect Public Health"},{"key":"2924_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10393-015-1053-0","volume":"13","author":"SAJ Leendertz","year":"2016","unstructured":"Leendertz SAJ, Gogarten JF, D\u00fcx A, et al. Assessing the evidence supporting fruit bats as the primary reservoirs for ebola viruses. EcoHealth. 2016;13:18\u201325. https:\/\/doi.org\/10.1007\/s10393-015-1053-0.","journal-title":"EcoHealth"},{"key":"2924_CR20","doi-asserted-by":"publisher","unstructured":"Wegner GI, Murray KA, Springmann M, Muller A, Sokolow SH, Saylors K, Morens DM. Averting wildlife-borne infectious disease epidemics requires a focus on socio-ecological drivers and a redesign of the global food system. EClinicalMedicine. 2022;47. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101386.","DOI":"10.1016\/j.eclinm.2022.101386"},{"key":"2924_CR21","doi-asserted-by":"publisher","unstructured":"Pigott DM, Golding N, Mylne A, Huang Z, Henry AJ, Weiss DJ, Brady OJ, Kraemer MU, Smith DL, Moyes CL, Bhatt S, Gething PW, Horby PW, Bogoch II, Brownstein JS, Mekaru SR, Tatem AJ, Khan K, Hay SI. Mapping the zoonotic niche of Ebola virus disease in Africa eLife. 2014;3:e04395. https:\/\/doi.org\/10.7554\/eLife.04395","DOI":"10.7554\/eLife.04395"},{"key":"2924_CR22","doi-asserted-by":"publisher","first-page":"1755594","DOI":"10.3389\/fmicb.2026.1755594","volume":"17","author":"N Farsiu","year":"2026","unstructured":"Farsiu N, Rezaie Zadeh Rukerd M, Khodadadpour Mahani F, Zeinali Nezhad N, Rahimi M, Mirtajadini FS, Pardeshenas M, Nakhaie M, Hassandarvish P. Emerging and re-emerging vector-borne and other zoonotic RNA viruses: pathogenesis, climate-driven dynamics, and strategies for global control. Front Microbiol. 2026;17:1755594. https:\/\/doi.org\/10.3389\/fmicb.2026.1755594.","journal-title":"Front Microbiol"},{"key":"2924_CR23","doi-asserted-by":"publisher","first-page":"100472","DOI":"10.1016\/j.ssmph.2019.100472","volume":"10","author":"KA Gr\u00e9pin","year":"2020","unstructured":"Gr\u00e9pin KA, Poirier MJ, Fox AM. The socio-economic distribution of exposure to Ebola: survey evidence from Liberia and Sierra Leone. SSM-population health. 2020;10:100472. https:\/\/doi.org\/10.1016\/j.ssmph.2019.100472.","journal-title":"SSM-population health"},{"key":"2924_CR24","doi-asserted-by":"publisher","unstructured":"Hewlett AL, Varkey JB, Smith PW, Ribner BS. Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units. Curr Opin Infect Dis. August 2015;28(4):343\u20138. https:\/\/doi.org\/10.1097\/QCO.0000000000000176.","DOI":"10.1097\/QCO.0000000000000176"},{"issue":"1","key":"2924_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.33546\/bnj.3069","volume":"10","author":"MT Stephens","year":"2024","unstructured":"Stephens MT, Dossen PC. The potential risk components and prevention measures of the Ebola virus disease outbreak in Liberia: An in-depth interview with the health workers and stakeholders. Belitung Nurs J. 2024;10(1):67. https:\/\/doi.org\/10.33546\/bnj.3069.","journal-title":"Belitung Nurs J"},{"key":"2924_CR26","doi-asserted-by":"publisher","unstructured":"Bausch DGRA. West Africa 2013: Re-examining Ebola. Microbiol Spectr. 2016;4.https:\/\/doi.org\/10.1128\/microbiolspec.ei10-0022-2016","DOI":"10.1128\/microbiolspec.ei10-0022-2016"},{"key":"2924_CR27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/vaccines10081213","volume":"10","author":"I Crozier","year":"2022","unstructured":"Crozier I, Britson KA, Wolfe DN, Klena JD, Hensley LE, Lee JS, Wolfraim LA, Taylor KL, Higgs ES, Montgomery JM, et al. The evolution of medical countermeasures for ebola virus disease: lessons learned and next steps. Vaccines. 2022;10:1213. https:\/\/doi.org\/10.3390\/vaccines10081213.","journal-title":"Vaccines"},{"key":"2924_CR28","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1038\/s41598-022-09564-4","volume":"12","author":"H Vossler","year":"2022","unstructured":"Vossler H, Akilimali P, Pan Y, et al. Analysis of individual-level data from 2018\u20132020 Ebola outbreak in Democratic Republic of the Congo. Sci Rep. 2022;12:5534. https:\/\/doi.org\/10.1038\/s41598-022-09564-4.","journal-title":"Sci Rep"},{"key":"2924_CR29","doi-asserted-by":"publisher","unstructured":"Guetiya Wadoum RE, Sevalie S, Minutolo A, Clarke A, Russo G, Colizzi V, Mattei M, Montesano C. The 2018\u20132020 Ebola outbreak in the Democratic Republic of Congo: a better response had been achieved through inter-state coordination in Africa. Risk management and healthcare policy. 2021 Dec 10:4923\u201330. https:\/\/doi.org\/10.2147\/RMHP.S327616","DOI":"10.2147\/RMHP.S327616"},{"key":"2924_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00705-023-05834-2","volume":"168","author":"N Biedenkopf","year":"2023","unstructured":"Biedenkopf N, Bukreyev A, Chandran K, et al. Renaming of genera Ebolavirus and Marburgvirus to Orthoebolavirus and Orthomarburgvirus, respectively, and introduction of binomial species names within family Filoviridae. Arch Virol. 2023;168:220. https:\/\/doi.org\/10.1007\/s00705-023-05834-2.","journal-title":"Arch Virol"},{"issue":"2","key":"2924_CR31","doi-asserted-by":"publisher","first-page":"001955","DOI":"10.1099\/jgv.0.001955","volume":"105","author":"N Biedenkopf","year":"2024","unstructured":"Biedenkopf N, Bukreyev A, Chandran K, Di Paola N, Formenty PB, Griffiths A, Hume AJ, M\u00fchlberger E, Netesov SV, Palacios G, Paw\u0119ska JT. ICTV virus taxonomy profile: Filoviridae 2024. J Gen Virol. 2024;105(2):001955. https:\/\/doi.org\/10.1099\/jgv.0.001955.","journal-title":"J Gen Virol"},{"key":"2924_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40121-023-00913-y","volume":"13","author":"F Almeida-Pinto","year":"2024","unstructured":"Almeida-Pinto F, Pinto R, Rocha J. Navigating the complex landscape of ebola infection treatment: a review of emerging pharmacological approaches. Infect Dis Ther. 2024;13:21\u201355. https:\/\/doi.org\/10.1007\/s40121-023-00913-y.","journal-title":"Infect Dis Ther"},{"key":"2924_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.coph.2021.06.010","volume":"60","author":"S Ghosh","year":"2021","unstructured":"Ghosh S, Saha A, Samanta S, Saha RP. Genome structure and genetic diversity in the Ebola virus. Curr Opin Pharmacol. 2021;60:83\u201390. https:\/\/doi.org\/10.1016\/j.coph.2021.06.010.","journal-title":"Curr Opin Pharmacol"},{"key":"2924_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40588-015-0021-3","volume":"2","author":"BA Rhein","year":"2015","unstructured":"Rhein BA, Maury WJ. Ebola virus entry into host cells: identifying therapeutic strategies. Curr Clin Micro Rpt. 2015;2:115\u201324. https:\/\/doi.org\/10.1007\/s40588-015-0021-3.","journal-title":"Curr Clin Micro Rpt"},{"issue":"33","key":"2924_CR35","doi-asserted-by":"publisher","first-page":"55750","DOI":"10.18632\/oncotarget.18498","volume":"8","author":"DS Yu","year":"2017","unstructured":"Yu DS, Weng TH, Wu XX, Wang FX, Lu XY, Wu HB, Wu NP, Li LJ, Yao HP. The lifecycle of the Ebola virus in host cells. Oncotarget. 2017;8(33):55750. https:\/\/doi.org\/10.18632\/oncotarget.18498.","journal-title":"Oncotarget"},{"key":"2924_CR36","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/cdd.2015.67","volume":"22","author":"L Falasca","year":"2015","unstructured":"Falasca L, Agrati C, Petrosillo N, et al. Molecular mechanisms of Ebola virus pathogenesis: focus on cell death. Cell Death Differ. 2015;22:1250\u20139. https:\/\/doi.org\/10.1038\/cdd.2015.67.","journal-title":"Cell Death Differ"},{"issue":"9","key":"2924_CR37","doi-asserted-by":"publisher","first-page":"e1001121","DOI":"10.1371\/journal.ppat.1001121","volume":"6","author":"A Nanbo","year":"2010","unstructured":"Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 2010;6(9):e1001121. https:\/\/doi.org\/10.1371\/journal.ppat.1001121.","journal-title":"PLoS Pathog"},{"key":"2924_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/2049-9957-3-43","volume":"3","author":"KY Lai","year":"2014","unstructured":"Lai KY, Ng WYG, Cheng FF. Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infect Dis Poverty. 2014;3:43. https:\/\/doi.org\/10.1186\/2049-9957-3-43.","journal-title":"Infect Dis Poverty"},{"issue":"6","key":"2924_CR39","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4161\/viru.1.6.12984","volume":"1","author":"DW Leung","year":"2010","unstructured":"Leung DW, Prins KC, Basler CF, Amarasinghe GK. Ebolavirus VP35 is a multifunctional virulence factor. Virulence. 2010;1(6):526\u201331. https:\/\/doi.org\/10.4161\/viru.1.6.12984.","journal-title":"Virulence"},{"key":"2924_CR40","doi-asserted-by":"publisher","unstructured":"Ilinykh PALubaki NMWiden SG, Renn LA, Theisen TC, Rabin RL, Wood TG, Bukreyev A. Different temporal effects of ebola virus VP35 and VP24 proteins on global gene expression in human dendritic cells. J Virol. 2015;89. https:\/\/doi.org\/10.1128\/jvi.00924-15.","DOI":"10.1128\/jvi.00924-15"},{"key":"2924_CR41","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/cdd.2015.67","volume":"22","author":"L Falasca","year":"2015","unstructured":"Falasca L, Agrati C, Petrosillo N, et al. Molecular mechanisms of Ebola virus pathogenesis: focus on cell death. Cell Death Differ. 2015;22:1250\u20139. https:\/\/doi.org\/10.1038\/cdd.2015.67.","journal-title":"Cell Death Differ"},{"key":"2924_CR42","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/pathogens9100850","volume":"9","author":"S Jain","year":"2020","unstructured":"Jain S, Khaiboullina SF, Baranwal M. Immunological perspective for ebola virus infection and various treatment measures taken to fight the disease. Pathogens. 2020;9:850. https:\/\/doi.org\/10.3390\/pathogens9100850.","journal-title":"Pathogens"},{"key":"2924_CR43","doi-asserted-by":"publisher","unstructured":"Schindell B.G., Webb A.L., Kindrachuk J. Persistence and sexual transmission of filoviruses. Viruses. 2018;10:683. https:\/\/doi.org\/10.3390\/v10120683.","DOI":"10.3390\/v10120683"},{"key":"2924_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nature19790","volume":"538","author":"E Holmes","year":"2016","unstructured":"Holmes E, Dudas G, Rambaut A, et al. The evolution of ebola virus: insights from the 2013\u20132016 epidemic. Nature. 2016;538:193\u2013200. https:\/\/doi.org\/10.1038\/nature19790.","journal-title":"Nature"},{"key":"2924_CR45","doi-asserted-by":"publisher","unstructured":"Seth D, Judson VJ, Munster S. The multiple origins of ebola disease outbreaks. Jo Inf Diseases.2023;228:S465\u2013S473. https:\/\/doi.org\/10.1093\/infdis\/jiad352","DOI":"10.1093\/infdis\/jiad352"},{"key":"2924_CR46","doi-asserted-by":"publisher","unstructured":"Whitfield ZJ, Prasad AN, Ronk AJ, Kuzmin IV, Ilinykh PA, Andino R, Bukreyev A. Species-specific evolution of Ebola virus during replication in human and bat cells. Cell Rep. 2020;32(7). https:\/\/doi.org\/10.1016\/j.celrep.2020.108028.","DOI":"10.1016\/j.celrep.2020.108028"},{"key":"2924_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","volume":"6","author":"ST Jacob","year":"2020","unstructured":"Jacob ST, Crozier I, Fischer WA, et al. Ebola virus disease. Nat Rev Dis Primers. 2020;6:13. https:\/\/doi.org\/10.1038\/s41572-020-0147-3.","journal-title":"Nat Rev Dis Primers"},{"key":"2924_CR48","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/microorganisms13020443","volume":"13","author":"ME Brisse","year":"2025","unstructured":"Brisse ME, Hickman HD. Viral infection and dissemination through the lymphatic system. Microorganisms. 2025;13:443. https:\/\/doi.org\/10.3390\/microorganisms13020443.","journal-title":"Microorganisms"},{"key":"2924_CR49","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ni1519","volume":"8","author":"C Zampieri","year":"2007","unstructured":"Zampieri C, Sullivan N, Nabel G. Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat Immunol. 2007;8:1159\u201364. https:\/\/doi.org\/10.1038\/ni1519.","journal-title":"Nat Immunol"},{"issue":"5","key":"2924_CR50","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.cell.2020.10.002","volume":"183","author":"D Kotliar","year":"2020","unstructured":"Kotliar D, Lin AE, Logue J, Hughes TK, Khoury NM, Raju SS, Wadsworth MH, Chen H, Kurtz JR, Dighero-Kemp B, Bjornson ZB. Single-cell profiling of Ebola virus disease in vivo reveals viral and host dynamics. Cell. 2020;183(5):1383\u2013401. https:\/\/doi.org\/10.1016\/j.cell.2020.10.002.","journal-title":"Cell"},{"key":"2924_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/82_2017_11","volume-title":"Marburg- and Ebolaviruses. Current Topics in Microbiology and Immunology","author":"C Mu\u00f1oz-Fontela","year":"2017","unstructured":"Mu\u00f1oz-Fontela C, McElroy AK. Ebola virus disease in humans: pathophysiology and immunity. In: M\u00fchlberger E, Hensley L, Towner J, editors. Marburg- and ebolaviruses. Current Topics in Microbiology and Immunology. Volume 411. Cham: Springer; 2017. https:\/\/doi.org\/10.1007\/82_2017_11."},{"key":"2924_CR52","doi-asserted-by":"publisher","unstructured":"Basler CFMikulasova A, Martinez-Sobrido L, Paragas J, M\u00fchlberger E, Bray MKlenk H, Palese P, Garc\u00eda-Sastre A. The ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol. 2003;77. https:\/\/doi.org\/10.1128\/jvi.77.14.7945-7956.2003.","DOI":"10.1128\/jvi.77.14.7945-7956.2003"},{"key":"2924_CR53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-025-02178-y","volume":"10","author":"J Nie","year":"2025","unstructured":"Nie J, Zhou L, Tian W, et al. Deep insight into cytokine storm: from pathogenesis to treatment. Sig Transduct Target Ther. 2025;10:112. https:\/\/doi.org\/10.1038\/s41392-025-02178-y.","journal-title":"Sig Transduct Target Ther"},{"key":"2924_CR54","doi-asserted-by":"publisher","first-page":"117177","DOI":"10.1016\/j.biopha.2024.117177","volume":"178","author":"NK Bhol","year":"2024","unstructured":"Bhol NK, Bhanjadeo MM, Singh AK, Dash UC, Ojha RR, Majhi S, Duttaroy AK, Jena AB. The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds. Biomed Pharmacother. 2024;178:117177. https:\/\/doi.org\/10.1016\/j.biopha.2024.117177.","journal-title":"Biomed Pharmacother"},{"key":"2924_CR55","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.3390\/ijms19092821","volume":"19","author":"E Nikitina","year":"2018","unstructured":"Nikitina E, Larionova I, Choinzonov E, Kzhyshkowska J. Monocytes and macrophages as viral targets and reservoirs. Int J Mol Sci. 2018;19:2821. https:\/\/doi.org\/10.3390\/ijms19092821.","journal-title":"Int J Mol Sci"},{"key":"2924_CR56","doi-asserted-by":"publisher","first-page":"619690","DOI":"10.3389\/fcvm.2021.619690","volume":"8","author":"JH Fosse","year":"2021","unstructured":"Fosse JH, Haraldsen G, Falk K, Edelmann R. Endothelial cells in emerging viral infections. Front Cardiovasc Med. 2021;8:619690. https:\/\/doi.org\/10.3389\/fcvm.2021.619690.","journal-title":"Front Cardiovasc Med"},{"key":"2924_CR57","doi-asserted-by":"publisher","unstructured":"Wahl-Jensen VMAfanasieva TASeebach J, Str\u00f6her UFeldmann H, Schnittler H. Effects of ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol. 2005;79. https:\/\/doi.org\/10.1128\/jvi.79.16.10442-10450.2005.","DOI":"10.1128\/jvi.79.16.10442-10450.2005"},{"key":"2924_CR58","doi-asserted-by":"publisher","unstructured":"Sanchez ALukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, Rollin PE. Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide Levels. J Virol. 2004;78. https:\/\/doi.org\/10.1128\/jvi.78.19.10370-10377.2004.","DOI":"10.1128\/jvi.78.19.10370-10377.2004"},{"key":"2924_CR59","doi-asserted-by":"publisher","unstructured":"Thomas W, Geisbert HA, Young, Peter B, Jahrling, Kelly J, Davis E, Kagan LE, Hensley. Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes\/macrophages is a key event. J Infect Diseases. 2003;288:1618\u20131629. https:\/\/doi.org\/10.1086\/379724","DOI":"10.1086\/379724"},{"key":"2924_CR60","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/cc13897","volume":"18","author":"N Petejova","year":"2014","unstructured":"Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014;18:224. https:\/\/doi.org\/10.1186\/cc13897.","journal-title":"Crit Care"},{"key":"2924_CR61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/v15020350","volume":"15","author":"AD Jayaprakash","year":"2023","unstructured":"Jayaprakash AD, Ronk AJ, Prasad AN, Covington MF, Stein KR, Schwarz TM, Hekmaty S, Fenton KA, Geisbert TW, Basler CF, et al. Marburg and ebola virus infections elicit a complex, muted inflammatory state in bats. Viruses. 2023;15:350. https:\/\/doi.org\/10.3390\/v15020350.","journal-title":"Viruses"},{"key":"2924_CR62","doi-asserted-by":"publisher","first-page":"634827","DOI":"10.3389\/fneur.2021.634827","volume":"12","author":"CRS McEntire","year":"2021","unstructured":"McEntire CRS, Song K-W, McInnis RP, Rhee JY, Young M, Williams E, Wibecan LL, Nolan N, Nagy AM, Gluckstein J, Mukerji SS, Mateen FJ. Neurologic manifestations of the World Health Organization\u2019s list of pandemic and epidemic diseases. Front Neurol. 2021;12:634827. https:\/\/doi.org\/10.3389\/fneur.2021.634827.","journal-title":"Front Neurol"},{"issue":"3","key":"2924_CR63","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13311-016-0457-z","volume":"13","author":"BJ Billioux","year":"2016","unstructured":"Billioux BJ, Smith B, Nath A. Neurological complications of Ebola virus infection. Neurotherapeutics. 2016;13(3):461\u201370. https:\/\/doi.org\/10.1007\/s13311-016-0457-z.","journal-title":"Neurotherapeutics"},{"key":"2924_CR64","doi-asserted-by":"publisher","first-page":"117311","DOI":"10.1016\/j.jns.2021.117311","volume":"421","author":"O Adekanmbi","year":"2021","unstructured":"Adekanmbi O, Ilesanmi O, Lakoh S, Ebola. A review and focus on neurologic manifestations. J Neurol Sci. 2021;421:117311. https:\/\/doi.org\/10.1016\/j.jns.2021.117311.","journal-title":"J Neurol Sci"},{"key":"2924_CR65","doi-asserted-by":"publisher","first-page":"1809435","DOI":"10.3389\/fcimb.2026.1809435","volume":"16","author":"H Li","year":"2026","unstructured":"Li H, Pickering BS. Viral RNA persistence and long-term consequences following acute infection with Risk Group 4 zoonotic viruses. Front Cell Infect Microbiol. 2026;16:1809435. https:\/\/doi.org\/10.3389\/fcimb.2026.1809435.","journal-title":"Front Cell Infect Microbiol"},{"key":"2924_CR66","doi-asserted-by":"publisher","unstructured":"Wilson HW, Amo-Addae M, Kenu, Ernest, Ilesanmi O, Stephen, Ameme DK, Sackey SO. Post-ebola syndrome among ebola virus disease survivors in Montserrado county, Liberia 2016. BioMed Res Int. 2018;8. https:\/\/doi.org\/10.1155\/2018\/1909410","DOI":"10.1155\/2018\/1909410"},{"key":"2924_CR67","doi-asserted-by":"publisher","unstructured":"Stawicki SP, Sharpe RP, Galwankar SC, Sweeney J, Martins N, Papadimos TJ, Jeanmonod D, Firstenberg MS, Paladino L, Hansoti B, Garg M. Reflections on the ebola public health emergency of international concern, part 1: post-ebola syndrome. J Glob Infect Diseases. 2017;9(2):p 41\u201344. https:\/\/doi.org\/10.4103\/jgid.jgid_20_17","DOI":"10.4103\/jgid.jgid_20_17"},{"key":"2924_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7116-9_3","volume-title":"Ebolaviruses. Methods in Molecular Biology","author":"V Vine","year":"2017","unstructured":"Vine V, Scott DP, Feldmann H. Ebolavirus: an overview of molecular and clinical pathogenesis. In: Hoenen T, Groseth A, editors. Ebolaviruses. Methods in Molecular Biology. Volume 1628. New York, NY: Humana; 2017. https:\/\/doi.org\/10.1007\/978-1-4939-7116-9_3."},{"issue":"6","key":"2924_CR69","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","volume":"163","author":"TW Geisbert","year":"2003","unstructured":"Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol. 2003;163(6):2347\u201370. https:\/\/doi.org\/10.1016\/S0002-9440(10)63591-2.","journal-title":"Am J Pathol"},{"key":"2924_CR70","doi-asserted-by":"publisher","unstructured":"Rivera A, Messaoudi I. Pathophysiology of Ebola virus infection: current challenges and future hopes. ACS Infect Diseases. 2015;1.5:186\u201397. https:\/\/doi.org\/10.1021\/id5000426","DOI":"10.1021\/id5000426"},{"key":"2924_CR71","doi-asserted-by":"publisher","first-page":"114316","DOI":"10.1016\/j.bcp.2020.114316","volume":"183","author":"M Carty","year":"2021","unstructured":"Carty M, Guy C, Bowie AG. Detection of viral infections by innate immunity. Biochem Pharmacol. 2021;183:114316. https:\/\/doi.org\/10.1016\/j.bcp.2020.114316.","journal-title":"Biochem Pharmacol"},{"key":"2924_CR72","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/v1031022","volume":"1","author":"A Summerfield","year":"2009","unstructured":"Summerfield A, McCullough KC. Dendritic cells in innate and adaptive immune responses against influenza virus. Viruses. 2009;1:1022\u201334. https:\/\/doi.org\/10.3390\/v1031022.","journal-title":"Viruses"},{"key":"2924_CR73","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41392-026-02710-8","volume":"11","author":"MH Andersen","year":"2026","unstructured":"Andersen MH. Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond. Sig Transduct Target Ther. 2026;11:130. https:\/\/doi.org\/10.1038\/s41392-026-02710-8.","journal-title":"Sig Transduct Target Ther"},{"key":"2924_CR74","doi-asserted-by":"publisher","first-page":"11740","DOI":"10.3390\/ijms231911740","volume":"23","author":"D Jarczak","year":"2022","unstructured":"Jarczak D, Nierhaus A. Cytokine Storm\u2014Definition, Causes, and Implications. Int J Mol Sci. 2022;23:11740. https:\/\/doi.org\/10.3390\/ijms231911740.","journal-title":"Int J Mol Sci"},{"key":"2924_CR75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40635-023-00582-8","volume":"11","author":"B Saravi","year":"2023","unstructured":"Saravi B, Goebel U, Hassenzahl LO, et al. Capillary leak and endothelial permeability in critically ill patients: a current overview. ICMx. 2023;11:96. https:\/\/doi.org\/10.1186\/s40635-023-00582-8.","journal-title":"ICMx"},{"key":"2924_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0873-8_4","volume-title":"Non-Pulmonary Complications of Critical Care. Respiratory Medicine","author":"R Martin","year":"2014","unstructured":"Martin R, Esper A, Martin GS. Hematologic complications. In: Richards J, Stapleton R, editors. Non-pulmonary complications of critical care. Respiratory Medicine. New York, NY: Humana; 2014. https:\/\/doi.org\/10.1007\/978-1-4939-0873-8_4."},{"key":"2924_CR77","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/v17091207","volume":"17","author":"VL Batista","year":"2025","unstructured":"Batista VL, Martins JR, Queiroz-Junior CM, Hottz ED, Teixeira MM, Costa VV. Mechanisms of thromboinflammation in viral infections\u2014a. Narrative Rev Viruses. 2025;17:1207. https:\/\/doi.org\/10.3390\/v17091207.","journal-title":"Narrative Rev Viruses"},{"issue":"01","key":"2924_CR78","doi-asserted-by":"publisher","first-page":"008","DOI":"10.1055\/a-1562-7599","volume":"122","author":"T Iba","year":"2022","unstructured":"Iba T, Levy JH, Levi M. Viral-induced inflammatory coagulation disorders: preparing for another epidemic. Thromb Haemost. 2022;122(01):008\u201319. https:\/\/doi.org\/10.1055\/a-1562-7599.","journal-title":"Thromb Haemost"},{"issue":"01","key":"2924_CR79","doi-asserted-by":"publisher","first-page":"008","DOI":"10.1055\/s-0042-1756300","volume":"122","author":"T Iba","year":"2022","unstructured":"Iba T, Levy JH, Levi M. Viral-induced inflammatory coagulation disorders: preparing for another epidemic. Thromb Haemost. 2022;122(01):008\u201319. https:\/\/doi.org\/10.1055\/s-0042-1756300.","journal-title":"Thromb Haemost"},{"issue":"2","key":"2924_CR80","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.64483\/202522315","volume":"2","author":"NA Alraee","year":"2025","unstructured":"Alraee NA, Alsayed TM, Najjar RA, Alshehri MA, Al Saigh HA, Almadani AA, Bajawi MY, Alsabai AM, Alkhifi MA, Alanazi MA, Almutairi GT. Marburg virus disease: epidemiological surveillance, public health preparedness, and infection control strategies within healthcare systems. Saudi J Med Public Health. 2025;2(2):1693\u2013710. https:\/\/doi.org\/10.64483\/202522315.","journal-title":"Saudi J Med Public Health"},{"key":"2924_CR81","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12575-024-00244-3","volume":"26","author":"K Muzammil","year":"2024","unstructured":"Muzammil K, Rayyani S, Abbas Sahib A, et al. Recent advances in crimean-congo hemorrhagic fever virus detection, treatment, and vaccination: overview of current status and challenges. Biol Proced Online. 2024;26:20. https:\/\/doi.org\/10.1186\/s12575-024-00244-3.","journal-title":"Biol Proced Online"},{"key":"2924_CR82","doi-asserted-by":"publisher","unstructured":"Qureshi AI. Clinical manifestations and laboratory diagnosis of Ebola virus infection. Ebola Virus Disease. 2016 Feb;19:117. https:\/\/doi.org\/10.1016\/B978-0-12-804230-4.00009-1.","DOI":"10.1016\/B978-0-12-804230-4.00009-1"},{"issue":"7","key":"2924_CR83","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.4103\/jfmpc.jfmpc_297_19","volume":"8","author":"S Hasan","year":"2019","unstructured":"Hasan S, Ahmad SA, Masood R, Saeed S. Ebola virus: A global public health menace: a narrative review. J family Med Prim care. 2019;8(7):2189\u2013201. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_297_19.","journal-title":"J family Med Prim care"},{"issue":"6","key":"2924_CR84","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jinf.2020.10.009","volume":"81","author":"KA Walsh","year":"2020","unstructured":"Walsh KA, Spillane S, Comber L, Cardwell K, Harrington P, Connell J, Teljeur C, Broderick N, De Gascun CF, Smith SM, Ryan M. The duration of infectiousness of individuals infected with SARS-CoV-2. J Infect. 2020;81(6):847\u201356. https:\/\/doi.org\/10.1016\/j.jinf.2020.10.009.","journal-title":"J Infect"},{"issue":"10","key":"2924_CR85","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3390\/microorganisms13102247","volume":"13","author":"A Borrego-Ruiz","year":"2025","unstructured":"Borrego-Ruiz A, Borrego JJ. The gut microbiome in enteric viral infections: underlying mechanisms and therapeutic approaches. Microorganisms. 2025;13(10):2247. https:\/\/doi.org\/10.3390\/microorganisms13102247.","journal-title":"Microorganisms"},{"key":"2924_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-024-10773-4","volume":"19","author":"A Choudhury","year":"2025","unstructured":"Choudhury A, Kulkarni AV, Arora V, et al. Acute-on-chronic liver failure (ACLF): the \u2018Kyoto Consensus\u2019\u2014steps from Asia. Hepatol Int. 2025;19:1\u201369. https:\/\/doi.org\/10.1007\/s12072-024-10773-4.","journal-title":"Hepatol Int"},{"issue":"16","key":"2924_CR87","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.4254\/wjh.v7.i16.1974","volume":"7","author":"M Dirchwolf","year":"2015","unstructured":"Dirchwolf M, Ruf AE. Role of systemic inflammation in cirrhosis: from pathogenesis to prognosis. World J Hepatol. 2015;7(16):1974\u201381. https:\/\/doi.org\/10.4254\/wjh.v7.i16.1974","journal-title":"World J Hepatol"},{"issue":"1","key":"2924_CR88","first-page":"29","volume":"13","author":"A McElroy","year":"2015","unstructured":"McElroy A. Understanding bleeding in ebola virus disease. Clin Adv Hematol Oncol. 2015;13(1):29.","journal-title":"Clin Adv Hematol oncology: H&O"},{"issue":"8","key":"2924_CR89","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1182\/blood-2017-10-804096","volume":"131","author":"M Levi","year":"2018","unstructured":"Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. J Am Soc Hematol. 2018;131(8):845\u201354. https:\/\/doi.org\/10.1182\/blood-2017-10-804096.","journal-title":"J Am Soc Hematol"},{"key":"2924_CR90","doi-asserted-by":"publisher","unstructured":"Benjamin M, Boral DJ, Williams, Leonard I, Boral DI, Coagulation. Am J Clin Pathol. 2016;146:670\u2013680. https:\/\/doi.org\/10.1093\/ajcp\/aqw195","DOI":"10.1093\/ajcp\/aqw195"},{"key":"2924_CR91","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.3390\/jcm12196128","volume":"12","author":"A Unar","year":"2023","unstructured":"Unar A, Bertolino L, Patauner F, Gallo R, Durante-Mangoni E. Decoding sepsis-induced disseminated intravascular coagulation: a comprehensive review of existing and emerging therapies. J Clin Med. 2023;12:6128. https:\/\/doi.org\/10.3390\/jcm12196128.","journal-title":"J Clin Med"},{"key":"2924_CR92","doi-asserted-by":"publisher","unstructured":"Broadhurst MJBrooks TJG, Pollock NR. Diagnosis of ebola virus disease: past, present, and future. Clin Microbiol Rev. 2016;29. https:\/\/doi.org\/10.1128\/cmr.00003-16.","DOI":"10.1128\/cmr.00003-16"},{"key":"2924_CR93","doi-asserted-by":"publisher","first-page":"e00862","DOI":"10.1016\/j.sciaf.2021.e00862","volume":"13","author":"C Kebenei","year":"2021","unstructured":"Kebenei C, Kipkorir, Patrick Okoth. Ebola virus disease, diagnostics and therapeutics: where is the consensus in over three decades of clinical Research? Sci Afr. 2021;13:e00862. https:\/\/doi.org\/10.1016\/j.sciaf.2021.e00862.","journal-title":"Sci Afr"},{"issue":"7","key":"2924_CR94","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1586\/erm.12.71","volume":"12","author":"A Niemz","year":"2012","unstructured":"Niemz A, Boyle DS. Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries. Expert Rev Mol Diagn. 2012;12(7):687\u2013701.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"2924_CR95","doi-asserted-by":"publisher","first-page":"e0006135","DOI":"10.1371\/journal.pntd.0006135","volume":"12","author":"P Raftery","year":"2018","unstructured":"Raftery P, Condell O, Wasunna C, Kpaka J, Zwizwai R, Nuha M, Fallah M, Freeman M, Harris V, Miller M, Baller A. Establishing Ebola Virus Disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: Impact on outbreak response, case management and laboratory systems strengthening. PLoS Negl Trop Dis. 2018;12(1):e0006135. https:\/\/doi.org\/10.1371\/journal.pntd.0006135.","journal-title":"PLoS Negl Trop Dis"},{"key":"2924_CR96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcv.2016.01.017","volume":"77","author":"P Cherpillod","year":"2016","unstructured":"Cherpillod P, Schibler M, Vieille G, Cordey S, Mamin A, Vetter P, Kaiser L. Ebola virus disease diagnosis by real-time RT-PCR: a comparative study of 11 different procedures. J Clin Virol. 2016;77:9\u201314. https:\/\/doi.org\/10.1016\/j.jcv.2016.01.017.","journal-title":"J Clin Virol"},{"key":"2924_CR97","doi-asserted-by":"publisher","unstructured":"Singh RK, Dhama K, Malik YS, Ramakrishnan MA, Karthik K, Khandia R, Joshi SK. Ebola virus \u2013 epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans \u2013 an update on its 40 year\u2019s journey. Vet Quart. 2017;37(1):98\u2013135. https:\/\/doi.org\/10.1080\/01652176.2017.1309474.","DOI":"10.1080\/01652176.2017.1309474."},{"issue":"5","key":"2924_CR98","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/bdra.23558","volume":"109","author":"LM Bebell","year":"2017","unstructured":"Bebell LM, Oduyebo T, Riley LE. Ebola virus disease and pregnancy: a review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth defects Res. 2017;109(5):353\u201362. https:\/\/doi.org\/10.1002\/bdra.23558.","journal-title":"Birth defects Res"},{"issue":"5\u20136","key":"2924_CR99","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0020-7519(03)00064-X","volume":"33","author":"MK Hart","year":"2003","unstructured":"Hart MK. Vaccine research efforts for filoviruses. Int J Parasitol. 2003;33(5\u20136):583\u201395. https:\/\/doi.org\/10.1016\/S0020-7519(03)00064-X.","journal-title":"Int J Parasitol"},{"key":"2924_CR100","doi-asserted-by":"publisher","unstructured":"Ren Q, Wang Y, Ma H, Xie J, Jin J, Tian R, Yu H, Gao X. Recent advances in lateral flow immunoassay for rapid diagnosis of viral diseases. Transbound Emerg Dis. 2026;5701806,:16. https:\/\/doi.org\/10.1155\/tbed\/5701806","DOI":"10.1155\/tbed\/5701806"},{"key":"2924_CR101","doi-asserted-by":"publisher","unstructured":"Kagame J, Kainulainen MH, Kabalisa E, Brangel P, Uwimana JM, Harmon JR, Mohamed NS, Benimana JL, Umwari A, Karaaslan E, Gasengayire A. Nucleoprotein and glycoprotein based serological assays for detection of Marburg virus infections. EBioMedicine. 2026;127. https:\/\/doi.org\/10.1016\/j.ebiom.2026.106244.","DOI":"10.1016\/j.ebiom.2026.106244"},{"issue":"1","key":"2924_CR102","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1021\/acsnano.7b07021","volume":"12","author":"P Brangel","year":"2018","unstructured":"Brangel P, Sobarzo A, Parolo C, Miller BS, Howes PD, Gelkop S, Lutwama JJ, Dye JM, McKendry RA, Lobel L, Stevens MM. A serological point-of-care test for the detection of IgG antibodies against Ebola virus in human survivors. ACS Nano. 2018;12(1):63\u201373. https:\/\/doi.org\/10.1021\/acsnano.7b07021.","journal-title":"ACS Nano"},{"key":"2924_CR103","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12250-018-0044-z","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu Y, Sun Y, Wu W, et al. Serological investigation of laboratory-confirmed and suspected ebola virus disease patients during the late phase of the ebola outbreak in sierra leone. Virol Sin. 2018;33:323\u201334. https:\/\/doi.org\/10.1007\/s12250-018-0044-z.","journal-title":"Virol Sin"},{"issue":"11","key":"2924_CR104","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/infdis\/jix486","volume":"216","author":"MH Kainulainen","year":"2017","unstructured":"Kainulainen MH, Nichol ST, Albari\u00f1o CG, Spiropoulou CF. Rapid determination of ebolavirus infectivity in clinical samples using a novel reporter cell line. J Infect Dis. 2017;216(11):1380\u20135. https:\/\/doi.org\/10.1093\/infdis\/jix486.","journal-title":"J Infect Dis"},{"key":"2924_CR105","doi-asserted-by":"publisher","DOI":"10.1007\/82_2017_19","volume-title":"Marburg- and Ebolaviruses. Current Topics in Microbiology and Immunology","author":"G Marshall Lyon","year":"2017","unstructured":"Marshall Lyon G, Mehta AK, Ribner BS. Clinical Management of Patients with Ebola Virus Disease in High-Resource Settings. In: M\u00fchlberger E, Hensley L, Towner J, editors. Marburg- and Ebolaviruses. Current Topics in Microbiology and Immunology. Volume 411. Cham: Springer; 2017. https:\/\/doi.org\/10.1007\/82_2017_19."},{"key":"2924_CR106","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00134-020-05949-z","volume":"46","author":"P Kiiza","year":"2020","unstructured":"Kiiza P, Mullin S, Teo K, et al. Treatment of Ebola-related critical illness. Intensive Care Med. 2020;46:285\u201397. https:\/\/doi.org\/10.1007\/s00134-020-05949-z.","journal-title":"Intensive Care Med"},{"issue":"3","key":"2924_CR107","doi-asserted-by":"publisher","first-page":"255","DOI":"10.15441\/ceem.23.065","volume":"10","author":"GJ Suh","year":"2023","unstructured":"Suh GJ, Kwon WY, Kim K, Jo YH, Choi SH, Chung SP, Kim WY. Korean Shock Society Investigators. Hemodynamic management of septic shock: beyond the Surviving Sepsis Campaign guidelines. Clin Experimental Emerg Med. 2023;10(3):255. https:\/\/doi.org\/10.15441\/ceem.23.065.","journal-title":"Clin Experimental Emerg Med"},{"issue":"2","key":"2924_CR108","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1093\/infdis\/jiae224","volume":"230","author":"MC Kasereka","year":"2024","unstructured":"Kasereka MC, Mukadi-Bamuleka D, Kitenge-Omasumbu R, Edidi-Atani F, Kuamfumu MM, Mulangu S, Tshiani-Mbaya O, Malengera Vicky K, Mbala-Kingebeni P, Ahuka-Mundeke S, Muyembe-Tamfum JJ, Rhabdomyolysis. Acute kidney injury, and mortality in ebola virus disease: retrospective analysis of cases from the eastern democratic Republic of the Congo, 2019. J Infect Dis. 2024;230(2):e465\u201373. https:\/\/doi.org\/10.1093\/infdis\/jiae224.","journal-title":"J Infect Dis"},{"key":"2924_CR109","doi-asserted-by":"publisher","first-page":"721328","DOI":"10.3389\/fimmu.2021.721328","volume":"12","author":"O Tshiani Mbaya","year":"2021","unstructured":"Tshiani Mbaya O, Mukumbayi P, Mulangu S. Review: insights on current FDA-approved monoclonal antibodies against ebola virus infection. Front Immunol. 2021;12:721328. https:\/\/doi.org\/10.3389\/fimmu.2021.721328.","journal-title":"Front Immunol"},{"key":"2924_CR110","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","volume":"21","author":"G Pantaleo","year":"2022","unstructured":"Pantaleo G, Correia B, Fenwick C, et al. Antibodies to combat viral infections: development strategies and progress. Nat Rev Drug Discov. 2022;21:676\u201396. https:\/\/doi.org\/10.1038\/s41573-022-00495-3.","journal-title":"Nat Rev Drug Discov"},{"key":"2924_CR111","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/biochem5010003","volume":"5","author":"M Ndayambaje","year":"2025","unstructured":"Ndayambaje M, Wahnou H, Naya A, Oudghiri M. Therapeutic management of ebola virus: targeting oxidative stress and inflammatory pathways. BioChem. 2025;5:3. https:\/\/doi.org\/10.3390\/biochem5010003.","journal-title":"BioChem"},{"key":"2924_CR112","doi-asserted-by":"publisher","unstructured":"Santoro MG, Carafoli E. Remdesivir: from Ebola to COVID-19. Biochem Biophys Res Commun. 2021;538:145\u201350. https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.043.","DOI":"10.1016\/j.bbrc.2020.11.043"},{"key":"2924_CR113","doi-asserted-by":"publisher","unstructured":"Porter D, Norquist B, Cihlar T, Remdesivir. Investigational antiviral drug with activity against ebola and other emerging and neglected viruses. https:\/\/doi.org\/10.1039\/9781788016858-00166","DOI":"10.1039\/9781788016858-00166"},{"issue":"10","key":"2924_CR114","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1080\/21645515.2019.1649532","volume":"15","author":"A Fathi","year":"2019","unstructured":"Fathi A, Dahlke C, Addo MM. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens. Hum Vaccines Immunotherapeutics. 2019;15(10):2269\u201385. https:\/\/doi.org\/10.1080\/21645515.2019.1649532.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"2924_CR115","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/biochem5010003","volume":"5","author":"M Ndayambaje","year":"2025","unstructured":"Ndayambaje M, Wahnou H, Naya A, Oudghiri M. Therapeutic management of ebola virus: targeting oxidative stress and inflammatory pathways. BioChem. 2025;5:3. https:\/\/doi.org\/10.3390\/biochem5010003.","journal-title":"BioChem"},{"issue":"1","key":"2924_CR116","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/03085147.2018.1448557","volume":"47","author":"AH Kelly","year":"2018","unstructured":"Kelly AH. Ebola vaccines, evidentiary charisma and the rise of global health emergency research. Econ Soc. 2018;47(1):135\u201361. https:\/\/doi.org\/10.1080\/03085147.2018.1448557.","journal-title":"Econ Soc"},{"key":"2924_CR117","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/vaccines11020268","volume":"11","author":"S Malik","year":"2023","unstructured":"Malik S, Kishore S, Nag S, Dhasmana A, Preetam S, Mitra O, Le\u00f3n-Figueroa DA, Mohanty A, Chattu VK, Assefi M, et al. Ebola virus disease vaccines: development, current perspectives & challenges. Vaccines. 2023;11:268. https:\/\/doi.org\/10.3390\/vaccines11020268.","journal-title":"Vaccines"},{"issue":"5\u20136","key":"2924_CR118","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/2051013615611017","volume":"3","author":"S Sridhar","year":"2015","unstructured":"Sridhar S. Clinical development of ebola vaccines. Ther Adv Vaccines. 2015;3(5\u20136):125\u201338. https:\/\/doi.org\/10.1177\/2051013615611017.","journal-title":"Therapeutic Adv Vaccines"},{"issue":"1","key":"2924_CR119","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21645515.2016.1225637","volume":"13","author":"Y Wang","year":"2017","unstructured":"Wang Y, Li J, Hu Y, Liang Q, Wei M, Zhu F. Ebola vaccines in clinical trial: The promising candidates. Hum Vaccines Immunotherapeutics. 2017;13(1):153\u201368. https:\/\/doi.org\/10.1080\/21645515.2016.1225637.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"2924_CR120","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41590-018-0233-9","volume":"19","author":"EO Saphire","year":"2018","unstructured":"Saphire EO, Schendel SL, Gunn BM, et al. Antibody-mediated protection against Ebola virus. Nat Immunol. 2018;19:1169\u201378. https:\/\/doi.org\/10.1038\/s41590-018-0233-9.","journal-title":"Nat Immunol"},{"key":"2924_CR121","doi-asserted-by":"publisher","unstructured":"Gunn BM, McNamara RP, Wood L, Taylor S, Devadhasan A, Guo W, Das J, Nilsson A, Shurtleff A, Dubey S, Eichberg M. Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates. Cell Rep. 2023;42(4). https:\/\/doi.org\/10.1016\/j.celrep.2023.112402.","DOI":"10.1016\/j.celrep.2023.112402"},{"key":"2924_CR122","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1038\/nature16041","volume":"528","author":"P Nouvellet","year":"2015","unstructured":"Nouvellet P, Garske T, Mills H, et al. The role of rapid diagnostics in managing Ebola epidemics. Nature. 2015;528:S109\u201316. https:\/\/doi.org\/10.1038\/nature16041.","journal-title":"Nature"},{"key":"2924_CR123","doi-asserted-by":"publisher","first-page":"e017285","DOI":"10.1136\/bmjgh-2024-017285","volume":"10","author":"D Musoke","year":"2025","unstructured":"Musoke D, Atusingwize E, Robins A, Nam S, Bonwitt J, Msukwa C, et al. Barriers to community engagement during the response to an Ebola virus disease outbreak in Uganda. BMJ Global Health. 2025;10:e017285. https:\/\/doi.org\/10.1136\/bmjgh-2024-017285.","journal-title":"BMJ Global Health"},{"key":"2924_CR124","doi-asserted-by":"publisher","unstructured":"Sau A. A simulation study on hypothetical ebola virus transmission in India Using Spatiotemporal Epidemiological Modeler (STEM): a way towards Precision Public Health. J Environ Public Health. 2017'7602301:8. https:\/\/doi.org\/10.1155\/2017\/7602301","DOI":"10.1155\/2017\/7602301"},{"key":"2924_CR125","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12098-015-1713-7","volume":"82","author":"V Mittal","year":"2015","unstructured":"Mittal V, Chhabra M, Venkatesh S. Ebola virus - an indian perspective. Indian J Pediatr. 2015;82:207\u20139. https:\/\/doi.org\/10.1007\/s12098-015-1713-7.","journal-title":"Indian J Pediatr"},{"issue":"15","key":"2924_CR126","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.clinmicnews.2015.07.004","volume":"37","author":"H Maity","year":"2015","unstructured":"Maity H, Stansilaus RP, Krishan A, Riya M, Zadeh VR, Mudgal PP, Arunkumar G. An online survey to assess awareness of Ebola virus disease. Clin Microbiol Newsl. 2015;37(15):123\u20135. https:\/\/doi.org\/10.1016\/j.clinmicnews.2015.07.004.","journal-title":"Clin Microbiol Newsl"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02924-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:02:22Z","timestamp":1786467742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02924-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":126,"alternative-id":["2924"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02924-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article is a review study and does not involve human participants, clinical samples, animal experiments, or patient data.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}